Jane Street’s Eledon Pharmaceuticals ELDN Stock Holding History

Jane Street’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.2K	Buy	+22,379	New	+$81.4K	﹤0.01%	10664
2026 Q1	–	Sell	-489,376	Closed	-$1.15M	–	11915
2025 Q4	$739K	Buy	489,376 +294,175	+151%	+$699K	﹤0.01%	6825
2025 Q3	$506K	Buy	+195,201	New	+$571K	﹤0.01%	7836
2025 Q2	–	Sell	-224,600	Closed	-$761K	–	9916
2025 Q1	$761K	Buy	224,600 +102,325	+84%	+$421K	﹤0.01%	6071
2024 Q4	$504K	Buy	+122,275	New	+$482K	﹤0.01%	6769
2023 Q3	–	Sell	-15,783	Closed	-$21.6K	–	8803
2023 Q2	$21.6K	Buy	+15,783	New	+$32.9K	﹤0.01%	8353
2020 Q3	–	Sell	-2,341	Closed	-$19K	–	7293
2020 Q2	$19K	Buy	+2,341	New	+$26.4K	﹤0.01%	6970
2019 Q3	–	Sell	-690	Closed	-$13K	–	5218
2019 Q2	$13K	Buy	+690	New	+$30.2K	﹤0.01%	5031

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Jane Street's ELDN Position: Q2 2026 in Review

Jane Street opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 22,379 shares worth $88.2K. The stake represents ﹤0.01% of the portfolio and ranks #10664 among its holdings. This is a return to the name: Jane Street previously reported a position in ELDN as recently as Q4 2025.

Jane Street first reported a position in ELDN in Q2 2019 and has held it in 8 quarters since. The position peaked at $761K in Q1 2025. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Jane Street held 22,379 shares of Eledon Pharmaceuticals worth $88.2K as of Q2 2026.
Eledon Pharmaceuticals was a new Jane Street position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10664 holding.
Jane Street first reported a position in Eledon Pharmaceuticals in Q2 2019 and has held it in 8 quarters since.
Jane Street's Eledon Pharmaceuticals position peaked at $761K in Q1 2025.
161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.